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IN this corn iunication, wereport,the first
quantitative evidence that systemieally
introduced BCG-activated macrophages
can reduce the entry of tumour cells into
the vascular channels of a primary trans-
planted tumour. In our experiments, the
tumour-host system is the T241 fibro-
sarcoma in the C57BL/6 mouse, which is
poorlv immunogenic and highly metastatic
(Liotta, Kleinerman and Saidel, 1974,
1976a). The primary tumouir is produced
by syngeineic transplantation of the
tumour cells into the femoral muscle of
the host. In previous studies (Liotta
et al., 1976b), transplantation of tumour
cells admixed with BCoG organisms
caused a reduction in the number of
spontaneous pulmoinary metastases and in
the number of tumour cells entering the
tumour vascular channels. Furthermore,
this treatment produced a higher propor-
tion of haematogenous tumour cells at-
tached to macrophages. Other investi-
gators (Eccles and Alexander, 1974; Wood
and Gillespie, 1975) have found an inverse
correlation between the formation of
spontaneous metastases and tumour
macrophage content. These results suggest
that circulating activated macrophages
may play an inhibitory role in the
haematogenous release and survival of
cells from established tumours. Activated
macrophages may also play a surveillance
role against spontaneously arising malig-
nant cells, as proposed by Evans and
Alexander (1976). However, no quantita-
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tive data have previously been available
to show a direct effect of macrophages on
the haematogenous release of cells from a
primary tumour.
BCGLactivated macrophages are non-
specifically cytotoxic, in that they do not
require recognition of specific antigens on
the tumour cell membrane (Evans and
Alexander, 1972). It is well established
that i.v.-injected macrophages sequester
first in the lungs and are later released
systemically to accumulate at sites of
inflammation (Roser, 1970; Perper,
Oronsky and Sanda, 1976). Thus, it is
reasonable to assume that at least some
i.v.-infused activated macrophages could
reach the site of tumour transplantation
and affect the entry rate of tumour cells
into the tumour vessels. To test this
hypothesis, we have studied the effects of
BCG-activated macrophages injected into
the tail vein of tumour-bearing mice.
In our experimental procedure, acti-
vated macrophages were obtained from
mice infected i.p. (Cleveland, Meltzer and
Zbar, 1974) with 6 x 106 colony-forming
units of BCG (Phipps TMC No. 1029) and
harvested by the method of Perper et al.
(1976). Seven days following BCG infec-
tion mice were killed by cervical disloca-
tion. The animals were exsanguinated and
immediately 5 ml of Hanks' balanced salt
solution with 2-5 i.u. heparin/ml were
injected i.p. The abdomen was gently
massaged and a small incision was made
through the linea alba to remove theL. A. LIOTTA, C. GATTOZZI, J. KLEINERMAN AND G. SAIDEL
exudate with a Pasteur pipette. The
exudate was incubated for 1 h in glass
Petri dishes, after which nonadherent cells
were removed by 3 washings. The yield
was 1 x 106-2.8 x 107 cells/ml. By 51Cr
release from tumour target cells, BCG-
activated macrophages were verified to be
10 x more cytotoxic (20/1 macrophage-
to-target cell ratio) than a comparable
number of macrophages induced by i.p.
mineral oil. In Experiments A and B (see
TABLE I.-Experimental Procedures and
Treatments
Experiment Day
A Tumour transplantation 0
Iv. injection of BCG-activated
peritoneal macrophages (no.)
1 4x106 3
0.5x106 6
1 4x106 9
0 9x106 12
1 7 x 106 15
1 0x 106 18
Perfusion of tumour and
excision of lungs 21
B Tumour transplantation 0
Iv. injection of BCG-activated
peritoneal macrophages (no.)
l-OX 106 11
0*4x 106 14
1-6x 106 17
0 7x106 20
Perfusion of tumour and
excision of lungs 21
C Tumour transplantation 0
Intra-tumour injection of BCG-
activated peritoneal
macrophages (no.)
1-2x106 11
1*2 x 106 14
0 6x106 17
0*9x 106 20
Perfusion of tumour and
excision of lungs 21
Table I) activated macrophages suspended
in Hanks' balanced salt solution were
injected i.v. In Experiment Cthe dose and
schedule were similar to B, but the acti-
vated macrophages were slowly injected
directly into the tumour mass. Control
animals received only Hanks' balanced
salt solution injections (0.2 ml) on the
same days the treated animals received
macrophage injections.
To demonstrate that systemically intro-
duced BCG-activated macrophages can
reduce the entry of tumour cells into the
vascular channels of a primary trans-
planted tumour, we used a perfusion
technique described previously (Liotta
et al., 1974, 1976a, b). Briefly, the tumour
vascular bed is perfused at physiological
pressure until a fixed volume of blood
effluent has been collected. The venous
effluent tumour cells collected on a
Nucleopore filter are then identified and
counted. As shown in our previous studies,
these effluent tumour cells represent the
cells present in the tumour vascular
channels at the time of perfusion. The
effect of the activated macrophages on
metastasis was evaluated by counting
pulmonary metastases after inflating the
excised lungs with 1-5 ml of neutral
buffered formalin. One week after fixation,
metastases were identified by both gross
inspection and microscopic examination
in serial sections through all lobes.
The experimental results in Table II
indicate that BOG-activated macrophages
injected i.v. can reduce the metastatic
rate in this transplanted tumour-host
system. A more significant reduction is
TABLE II.-Effects of BCG-activated Macrophaqes on Metastasis
Venous effluent tumour
cells/ml mean±s.d.
23±11***
139±72
93±42**
132±68
102±48*
145±82
t Macroscopic pulmonary
metastases mean ±s.d.
3-0±3-8***
19-2±5*1
13- 1±42**
20-0±6 - 3
16-8±4 3*
18-7±5-1
$ Microscopic pulmonary
metastases mean ±s.d.
2.0±0.7***
6 - 772 * 3
4* 1±29*
74 - 42 *9
4-8±2.0*
6*2±2 *4
Students t test: ***P<0-001; **P<0*05; *P>0.05.
t >0 5 mm in greatest dimension.
I < 0* 5 mm in greatest dimension.
Experiment
(no. animals)
A (8)
control (8)
B (8)
control (7)
C (8)
control (7)
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seen when the macrophages are injected
earlier in the course of tumour growth.
This reduction in metastatic rate occurs
without significant alteration in the pri-
mary tumour size, proportion of necrosis,
or vascularity. When macrophage injec-
tions are begun early, the number of
tumour cells collected in the tumour
venous effluent is greatly reduced. Macro-
phages injected directly into the tumour
mass do not significantly reduce meta-
stases. However, some foci of ulceration
and necrosis were noted at the injection
site.
In experiment A there is definite
quantitative evidence that systemically
introduced macrophages can depress entry
of tumour cells into vascular channels of
the primary tumour. The failure of inter-
tumour macrophages to reduce metastases
may have been due to their sequestration
at the injection site, where the ratio of
tumourcellstomacrophageswouldbehigh.
As shown by Fidler (1974), specifically
activated macrophages injected i.v. can
reduce the formation of artificial pul-
monary metastases from tumour cells
injected i.v. The present study uses
nonspecifically activated macrophages to
prevent spontaneous metastasis. Inhibi-
tion of the metastatic process by circu-
lating macrophages may have occurred
both in the lung and at the primary
tumour.
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